ALRG yields 0.51% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 5
Combined, ALRG + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ALRG + JNJ for your $10,000?
ALRG is actively managed and invests primarily in equity securities of large-cap US companies within the S&P 500 Index range. It employs a disciplined process that combines fundamental analysis and a proprietary valuation framework to identify price inefficiencies in high-quality companies. These companies are believed to have strong growth prospects, competitive advantages, solid financial conditions, and aligned shareholder interests. Sustainability considerations, including material ESG risks, are assessed using in-house methodologies and scores. The fund may sell securities upon meeting valuation expectations, deteriorating fundamentals, or the availability of more attractive opportunities. As a non-diversified fund, it invests in fewer issuers and may use futures contracts to equitize cash. The fund seeks long-term capital appreciation.
Full ALRG Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.